PARP1 and cholangiocarcinoma: When the IC50 concentration of HCQ was used for cholangiocarcinoma administration, we confirmed that the number of apoptotic cells and the expression of apoptosis-related proteins (cleaved caspase 3 and cleaved PARP1) increased significantly, accompanied by G1 phase arrest.